Net Medical ( OTCPK:NMXS ) announced that it has been invited to participate with Accorto Regulatory Solutions at the Medical Design & Manufacturing (MD&M) trade show in Anaheim, CA in February.
Its participation with Accorto at the trade show underscores the growing need for clinical studies for international and domestic medical product developers.
While Accorto handles the regulatory aspect of streamlining the process of filing with the FDA to demonstrate product safety and efficacy, Net Medical's role is to conduct the clinical studies under the guidance of Accorto throughout the state of New Mexico, as a critical part of Accorto's growing network of clinical partners.
President Rafael Rubio said, "Clinical trials, which advance medical knowledge of diagnosis, treatment and disease prevention, have become an important part of our business growth. Sponsored by medical device companies, academic medical centers, voluntary groups and health care providers, these trials are essential in developing new treatments and medications, identifying the causes of illnesses and developing new diagnostic tools. During a trial, information is gained about the effectiveness of the device or treatment and how promising new advances are to individuals and scientists."
For further details see:
Net Medical grows partnership with Accorto Regulatory Solutions